EPGNF - Epigenomics AG

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.85M
Enterprise Value -13.50M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.53
Price/Book (mrq)0.18
Enterprise Value/Revenue -23.82
Enterprise Value/EBITDA 2.07

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 363.64%
S&P500 52-Week Change 33.90%
52 Week High 31.7600
52 Week Low 30.2400
50-Day Moving Average 30.7086
200-Day Moving Average 30.7255

Share Statistics

Avg Vol (3 month) 3144
Avg Vol (10 day) 3N/A
Shares Outstanding 54.09M
Implied Shares Outstanding 6N/A
Float 82.14M
% Held by Insiders 133.12%
% Held by Institutions 14.86%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 0.00%
Operating Margin (ttm)-3,150.99%

Management Effectiveness

Return on Assets (ttm)-59.23%
Return on Equity (ttm)-126.60%

Income Statement

Revenue (ttm)504k
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)16.50%
Gross Profit (ttm)N/A
EBITDA -14.32M
Net Income Avi to Common (ttm)-14.96M
Diluted EPS (ttm)-2.1000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.89M
Total Cash Per Share (mrq)1.61
Total Debt (mrq)439k
Total Debt/Equity (mrq)9.66
Current Ratio (mrq)1.21
Book Value Per Share (mrq)1.06

Cash Flow Statement

Operating Cash Flow (ttm)-12.03M
Levered Free Cash Flow (ttm)-5.6M